Home Cart 0 Sign in  
X

[ CAS No. 319-24-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 319-24-4
Chemical Structure| 319-24-4
Chemical Structure| 319-24-4
Structure of 319-24-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 319-24-4 ]

Related Doc. of [ 319-24-4 ]

Alternatived Products of [ 319-24-4 ]

Product Details of [ 319-24-4 ]

CAS No. :319-24-4 MDL No. :MFCD03791308
Formula : C8H8FNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :PUDDYSBKCDKATP-UHFFFAOYSA-N
M.W : 169.15 Pubchem ID :2783401
Synonyms :

Calculated chemistry of [ 319-24-4 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.08
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.67
Log Po/w (XLOGP3) : 2.77
Log Po/w (WLOGP) : 1.62
Log Po/w (MLOGP) : 1.75
Log Po/w (SILICOS-IT) : 1.4
Consensus Log Po/w : 1.84

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.87
Solubility : 0.227 mg/ml ; 0.00134 mol/l
Class : Soluble
Log S (Ali) : -3.52
Solubility : 0.0506 mg/ml ; 0.000299 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.39
Solubility : 0.692 mg/ml ; 0.00409 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.33

Safety of [ 319-24-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 319-24-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 319-24-4 ]
  • Downstream synthetic route of [ 319-24-4 ]

[ 319-24-4 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 319-24-4 ]
  • [ 77287-34-4 ]
  • [ 16499-56-2 ]
Reference: [1] Bioorganic Chemistry, 2018, vol. 80, p. 433 - 443
  • 2
  • [ 319-24-4 ]
  • [ 16499-61-9 ]
Reference: [1] Bioorganic Chemistry, 2018, vol. 80, p. 433 - 443
  • 3
  • [ 319-24-4 ]
  • [ 63069-49-8 ]
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 152, p. 235 - 252
  • 4
  • [ 393-85-1 ]
  • [ 319-24-4 ]
YieldReaction ConditionsOperation in experiment
88% With hydrogen In methanol for 120 h; Step 1 : Preparation of 2-Amino-5-fluoro-benzoic acid methyl ester :; To a solution OF 5-FLUORO-2-NITRO-BENZOIC acid methyl ester (24. 8 g, 125 mmol) in CH30H was added 10percent BY WEIGHT PD on activated carbon (2. 58 g) under nitrogenous atmosphere. The vessel was then purged with and stirred under 1 atmosphere H2 for 5 d. FILTRATION THROUGH CELITE and silica gel chromatography eluting with a gradient of 0 to 30percent ethyl acetate in hexanes afforded 19. 7 g (88percent) of the title compound as a yellow OIL. 1H NMR (300 MHz, CDC13) B 7. 53 (dd, J= 3. 1, 9. 7 Hz, 1H), 7. 03 (DDD, J= 3. 1, 7. 8, 9. 0 Hz, 1H), 6. 62 (dd, J= 4. 5, 9. 0 Hz, 1H), 5. 57 (br s, 2H), 3. 87 (s, 3H) ; 19F NMR (282 MHz, CDC13) ppm-128. 80 (ddd, J= 4. 9, 8. 0, 9. 7 Hz) ; LC/MS : FA standard Rt = 1. 60 min, EX 170. 07.
Reference: [1] Patent: WO2005/28474, 2005, A2, . Location in patent: Page/Page column 201-202
[2] Journal of the American Chemical Society, 1944, vol. 66, p. 1165
  • 5
  • [ 67-56-1 ]
  • [ 446-08-2 ]
  • [ 319-24-4 ]
YieldReaction ConditionsOperation in experiment
42%
Stage #1: at 100℃;
Stage #2: With water; potassium carbonate In dichloromethane
Intermediate 53; Methyl 2-amino-5-fluorobenzoateA solution of 2-amino-5-fluorobenzoic acid (9.29 mmol, 1.440 g) in a mixture of HCI/MeOH (3N, 30 ml) was heated at 1000C overnight. The solvent was evaporated and the crude mixture was extracted between DCM and K2CO3 saturated aqueous solution. The organic phase was evaporated and the crude mixture was purified by chromatography over SiO2 with hexane/ethyl acetate mixtures affording 0.650 g (yield 42percent) of the expected product. <n="67"/>δ 1H NMR (200 MHz, CDCI3): 3.9 (s, 3H), 5.6 (s, 2H), 6.6 (dd, J=9.0, 4.7 Hz1 1 H), 7.0 (m, 1 H), 7.5 (dd, J=9.8, 3.1 Hz, 1 H). ESI/MS (m/e, percent): 170 [(M+1)\\ 100].
Reference: [1] Patent: WO2009/21696, 2009, A1, . Location in patent: Page/Page column 65-66
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 24, p. 5923 - 5936
[3] Chemistry of Heterocyclic Compounds, 2006, vol. 42, # 1, p. 64 - 69
[4] Journal of Heterocyclic Chemistry, 2010, vol. 47, # 2, p. 415 - 420
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 21, p. 8332 - 8338
[6] Journal of Organic Chemistry, 2015, vol. 80, # 21, p. 11175 - 11183
[7] Advanced Synthesis and Catalysis, 2018, vol. 360, # 10, p. 1919 - 1925
  • 6
  • [ 446-08-2 ]
  • [ 18107-18-1 ]
  • [ 319-24-4 ]
Reference: [1] Patent: WO2007/9774, 2007, A1, . Location in patent: Page/Page column 22
  • 7
  • [ 80-11-5 ]
  • [ 446-08-2 ]
  • [ 319-24-4 ]
Reference: [1] Heterocycles, 2006, vol. 67, # 1, p. 161 - 173
  • 8
  • [ 320-98-9 ]
  • [ 319-24-4 ]
Reference: [1] Journal of the American Chemical Society, 1944, vol. 66, p. 1165
  • 9
  • [ 394-02-5 ]
  • [ 319-24-4 ]
Reference: [1] Journal of the American Chemical Society, 1944, vol. 66, p. 1165
  • 10
  • [ 319-24-4 ]
  • [ 877264-43-2 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 17, p. 5190 - 5193
  • 11
  • [ 319-24-4 ]
  • [ 57-13-6 ]
  • [ 88145-90-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1593 - 1597
  • 12
  • [ 319-24-4 ]
  • [ 134517-57-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 6, p. 1593 - 1597
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 319-24-4 ]

Fluorinated Building Blocks

Chemical Structure| 2475-81-2

[ 2475-81-2 ]

Methyl 2-amino-4-fluorobenzoate

Similarity: 0.97

Chemical Structure| 207346-42-7

[ 207346-42-7 ]

Methyl 2-amino-4,5-difluorobenzoate

Similarity: 0.95

Chemical Structure| 144851-82-1

[ 144851-82-1 ]

Methyl 2-amino-3-fluorobenzoate

Similarity: 0.95

Chemical Structure| 185629-32-7

[ 185629-32-7 ]

Methyl 4-amino-3-fluorobenzoate

Similarity: 0.94

Chemical Structure| 369-26-6

[ 369-26-6 ]

Methyl 3-amino-4-fluorobenzoate

Similarity: 0.92

Aryls

Chemical Structure| 2475-81-2

[ 2475-81-2 ]

Methyl 2-amino-4-fluorobenzoate

Similarity: 0.97

Chemical Structure| 207346-42-7

[ 207346-42-7 ]

Methyl 2-amino-4,5-difluorobenzoate

Similarity: 0.95

Chemical Structure| 144851-82-1

[ 144851-82-1 ]

Methyl 2-amino-3-fluorobenzoate

Similarity: 0.95

Chemical Structure| 185629-32-7

[ 185629-32-7 ]

Methyl 4-amino-3-fluorobenzoate

Similarity: 0.94

Chemical Structure| 369-26-6

[ 369-26-6 ]

Methyl 3-amino-4-fluorobenzoate

Similarity: 0.92

Esters

Chemical Structure| 2475-81-2

[ 2475-81-2 ]

Methyl 2-amino-4-fluorobenzoate

Similarity: 0.97

Chemical Structure| 207346-42-7

[ 207346-42-7 ]

Methyl 2-amino-4,5-difluorobenzoate

Similarity: 0.95

Chemical Structure| 144851-82-1

[ 144851-82-1 ]

Methyl 2-amino-3-fluorobenzoate

Similarity: 0.95

Chemical Structure| 185629-32-7

[ 185629-32-7 ]

Methyl 4-amino-3-fluorobenzoate

Similarity: 0.94

Chemical Structure| 369-26-6

[ 369-26-6 ]

Methyl 3-amino-4-fluorobenzoate

Similarity: 0.92

Amines

Chemical Structure| 2475-81-2

[ 2475-81-2 ]

Methyl 2-amino-4-fluorobenzoate

Similarity: 0.97

Chemical Structure| 207346-42-7

[ 207346-42-7 ]

Methyl 2-amino-4,5-difluorobenzoate

Similarity: 0.95

Chemical Structure| 144851-82-1

[ 144851-82-1 ]

Methyl 2-amino-3-fluorobenzoate

Similarity: 0.95

Chemical Structure| 185629-32-7

[ 185629-32-7 ]

Methyl 4-amino-3-fluorobenzoate

Similarity: 0.94

Chemical Structure| 369-26-6

[ 369-26-6 ]

Methyl 3-amino-4-fluorobenzoate

Similarity: 0.92